COVID-19 infection poses a greater diagnosis and therapy challenge in patients with cancer. Therefore, they could be at increased risk of developing severe forms and have a bad prognosis.
haematological manifestations are described in COVID 19 infection and often induced by cancer treatments. This can sometimes lead us to miss the diagnosis of COVID 19 infection.
In this work, we analyzed clinical and biological profiles of three patients with confirmed COVID-19 infection, who had different cancers treatment protocols, and we noticed that they all had lymphocytic-predominant pancytopenia. However, this haematological abnormalities can be a predictive factor for the occurrence of severe forms in our context.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
